A phase II study of nivolumab and ipilimumab with radiation therapy in patients with metastatic, microsatellite stable pancreatic adenocarcinoma

被引：0
|
作者：
Koenig, Julie L.
Pappas, Leon
Yeap, Beow Y.
Clark, Jeffrey William
Weekes, Colin D.
Allen, Jill N.
Blaszkowsky, Lawrence Scott
Ryan, David P.
Cleary, James M.
Mancias, Joseph Douglas
Schlechter, Benjamin L.
Slater, Sarah Elizabeth
Wo, Jennifer Yon-Li
Roberts, Hannah Johnson
Von Fedak, Sofia
Carzo, Nicole
Drapek, Lorraine C.
Mehta, Arnav
Hong, Theodore S.
Parikh, Aparna Raj
机构：
[1] Harvard Radiat Oncol Program, Boston, MA USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Div Hematol & Oncol, Dept Med, Boston, MA USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[4] Dana Farber Canc Inst, Boston, MA USA
[5] Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA USA
[6] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4143
引用
收藏
页数：1
相关论文
共 50 条
  • [21] PHASE II STUDY OF IPILIMUMAB AND NIVOLUMAB IN LEPTOMENINGEAL CARCINOMATOSIS
    Strickland, Matthew
    Lee, Eudocia Quant
    Wang, Nancy
    Cohen, Justine
    Chukwueke, Ugonma
    Forst, Deborah
    Eichler, April
    Overmoyer, Beth
    Lin, Nancy
    Chen, Wendy
    Bardia, Aditya
    Juric, Dejan
    Dagogo-Jack, Ibiayi
    White, Michael
    Dietrich, Jorg
    Nayyar, Naema
    Kim, Albert
    Alvarez-Breckenridge, Christopher
    Mahar, Maura
    Mora, Joana
    Nahed, Brian
    Jones, Pamela
    Shih, Helen
    Gerstner, Elizabeth
    Giobbie-Hurder, Anita
    Carter, Scott
    Oh, Kevin
    Cahill, Daniel
    Sullivan, Ryan
    Brastianos, Priscilla
    NEURO-ONCOLOGY, 2021, 23 : 49 - 49
  • [22] Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis
    Priscilla K. Brastianos
    Matthew R. Strickland
    Eudocia Quant Lee
    Nancy Wang
    Justine V. Cohen
    Ugonma Chukwueke
    Deborah Anne Forst
    April Eichler
    Beth Overmoyer
    Nancy U. Lin
    Wendy Y. Chen
    Aditya Bardia
    Dejan Juric
    Ibiayi Dagogo-Jack
    Michael D. White
    Jorg Dietrich
    Naema Nayyar
    Albert E. Kim
    Christopher Alvarez-Breckenridge
    Maura Mahar
    Joana L. Mora
    Brian V. Nahed
    Pamela S. Jones
    Helen A. Shih
    Elizabeth R. Gerstner
    Anita Giobbie-Hurder
    Scott L. Carter
    Kevin Oh
    Daniel P. Cahill
    Ryan J. Sullivan
    Nature Communications, 12
  • [23] Phase I/II Study of Ipilimumab for Patients With Metastatic Melanoma
    Weber, Jeffrey S.
    O'Day, Steven
    Urba, Walter
    Powderly, John
    Nichol, Geoff
    Yellin, Michael
    Snively, Jolie
    Hersh, Evan
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (36) : 5950 - 5956
  • [24] Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinoma
    Belli, Carmen
    Piemonti, Lorenzo
    D'Incalci, Maurizio
    Zucchetti, Massimo
    Porcu, Luca
    Cappio, Stefano
    Doglioni, Claudio
    Allavena, Paola
    Ceraulo, Domenica
    Maggiora, Paola
    Dugnani, Erica
    Cangi, Maria Giulia
    Garassini, Greta
    Reni, Michele
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (03) : 477 - 484
  • [25] Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinoma
    Carmen Belli
    Lorenzo Piemonti
    Maurizio D’Incalci
    Massimo Zucchetti
    Luca Porcu
    Stefano Cappio
    Claudio Doglioni
    Paola Allavena
    Domenica Ceraulo
    Paola Maggiora
    Erica Dugnani
    Maria Giulia Cangi
    Greta Garassini
    Michele Reni
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 477 - 484
  • [26] Pathology of durable stable disease in melanoma patients treated with ipilimumab, nivolumab, or ipilimumab, and nivolumab combination therapy.
    Buchbinder, Elizabeth Iannotti
    Pfaff, Kathleen L.
    Manos, Michael P.
    Ouyang, Olivia
    Ott, Patrick Alexander
    Rodig, Scott J.
    Hodi, F. Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [27] A Phase II Study of Nivolumab or Ipilimumab With or Without Azacitidine for Patients With Myelodysplastic Syndrome
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (02) : 11 - 12
  • [28] Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study
    Elez, Elena
    Cubillo, Antonio
    Alfonso, Pilar Garcia
    Middleton, Mark R.
    Chau, Ian
    Alkuzweny, Baha
    Alcasid, Ann
    Zhang, Xiaosong
    Van Cutsem, Eric
    BMC CANCER, 2024, 24 (01)
  • [29] A phase II study of niraparib and dostarlimab with radiation in patients with metastatic pancreatic cancer
    Parikh, Aparna Raj
    Weekes, Colin D.
    Blaszkowsky, Lawrence Scott
    Franses, Joseph Wang
    Ting, David Tsai
    Mehta, Arnav
    Roeland, Eric
    Ryan, David P.
    Allen, Jill N.
    Clark, Jeffrey William
    Ly, Leilana
    Loosbrock, Isabella
    Jarnagin, Joy X.
    Bannon, Allison
    Caldwell, Darcy K.
    Yeap, Beow Y.
    Wo, Jennifer Y.
    Hong, Theodore S.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [30] A phase II study of nivolumab in patients with recurrent or metastatic carcinosarcomas
    Kim, Miso
    Hong, Jung Yong
    Kim, Min Hwan
    Jung, Minkyu
    Kim, Gun Min
    Kim, Kyoo Hyun
    Yun, Kum-Hee
    Shin, Su-Jin
    Lee, Young Han
    Park, Jiwoo
    Lee, Jeeyun
    Kim, Hyo Song
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345